-+ 0.00%
-+ 0.00%
-+ 0.00%

CARDIFF ONCOLOGY RECEIVES FDA FAST TRACK DESIGNATION FOR ONVANSERTIB IN FIRST-LINE RAS-MUTATED METASTATIC COLORECTAL CANCER

Reuters·11/16/2026 12:00:01

Please log in to view news